Oscient Pharmaceuticals Corporation (NASDAQ: OSCI)

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI), a commercial-stage pharmaceutical company, is devoted to marketing two FDA-approved products in the United States: ANTARA® capsules, a cardiovascular product; and FACTIVE® tablets, a fluoroquinolone antibiotic. ANTARA is designed to treat hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet. FACTIVE is designed to treat acute bacterial exacerbations of chronic bronchitis and pneumonia. For further information, visit the Company’s web site at www.oscient.com.